TRDA
Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
TRDA fundamentals
Entrada Therapeutics (TRDA) released its earnings on Aug 6, 2025: revenue was 1.95M (YoY -97.94%), missed estimates; EPS was -1.04 (YoY -167.10%), missed estimates.
Revenue / YoY
1.95M
-97.94%
EPS / YoY
-1.04
-167.10%
Report date
Aug 6, 2025
Earnings
EPS
Revenue
Revenue & Expenses
TRDA has released its 2025 Q4 earnings report, with revenue of 1.30M, reflecting a YoY change of -96.53%, and net profit of -39.16M, showing a YoY change of -3562.78%. The Sankey diagram below clearly presents TRDA's revenue sources and cost distribution.
Key Indicators
Entrada Therapeutics (TRDA) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Entrada Therapeutics (TRDA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Entrada Therapeutics (TRDA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Entrada Therapeutics (TRDA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Entrada Therapeutics (TRDA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Entrada Therapeutics (TRDA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Entrada Therapeutics's latest dividend and current dividend yield?What does Entrada Therapeutics do and what are its main business segments?What is Entrada Therapeutics's gross profit margin?Did Entrada Therapeutics beat or miss consensus estimates last quarter?What guidance did Entrada Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Entrada Therapeutics next quarter?What were the key takeaways from Entrada Therapeutics's earnings call?What is the revenue and EPS growth rate for Entrada Therapeutics year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
